The Patience of Patients - Study participants are waiting on eClinical technology to catch up.

Patient centricity.   Patient engagement.  Patient driven studies.   It seems lately that the word “patient” is part and parcel to any marketing message or strategy for companies that conduct clinical research.   And this is obviously a good thing. Patient participation in developing novel therapies can help guide strategy and investment for trial sponsors while bringing to market treatments that promise better quality of life and increased effectiveness for patients.  

people on phones.JPG

 As web and mobile technology continue to improve at an incredible pace, implementation of this technology in clinical research has historically lagged the consumer market adoption.   Patients are using mobile technology to perform the most basic everyday tasks on easy-to-use modern interfaces.   The average person can build their own website, order groceries, produce their own video and author their own blog in one morning, all from a smartphone.  We are sharing more data actively and passively than in anytime in history, so why are many studies still using paper to capture eCOA and other patient data? Why aren’t some of the more innovative technologies making it into clinical trials faster?

 There are a few obvious answers.   Regulatory requirements and technology costs come to mind.  However, there is a third possible reason that the industry isn’t talking about as much, implementation burden.   Using eCOA as an example, CRO’s and pharmaceutical companies are required to retain highly skilled technical staff to implement technology for capturing patient data in a study.  Custom software coding and configuration is often needed to produce the desired patient or clinician experience, requiring more time and money to make that happen.   

 The adoption of the latest technology in clinical trials, may not actually be hindered by risk aversion, regulatory requirements or lack of budget from pharmaceutical companies or CRO’s.   It could be that there is currently no easy way of building and deploying an optimal patient data collection solution, making it too burdensome to be cost effective while maintaining quality, meeting deadlines and adhering to regulatory requirements.

 At Altavoz, we’re focused on reducing implementation burden in order to narrow the gap between consumer technology advancements and their eventual adoption in to clinical research.  By using modern web and mobile technology, we provide an interface that’s easy enough that  most employees can configure and deploy their own eCOA and medication adherence diary, without advanced technical knowledge.

 If patient centricity is truly part of the greater strategy to bring better drugs to market faster, we must provide sponsors and CRO’s better tools to reduce the burden to implement technology to accomplish that goal.   Reducing implementation burden allows electronic capture of patient data on more studies.   That’s how we amplify the patient’s voice in clinical research.

Interested in learning more or seeing Altavoz Sculptor in action?   Contact us to schedule a demo or become a Certified Altavoz Sculptor today!  Going to DIA?   Come by and see us at booth #407!